[Lansoprazol]

Gastroenterol Hepatol. 1995 Feb;18(2):101-9.
[Article in Spanish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents / adverse effects
  • Anti-Ulcer Agents / therapeutic use*
  • Controlled Clinical Trials as Topic
  • Duodenal Ulcer / drug therapy
  • Esophagitis, Peptic / drug therapy
  • Gastroesophageal Reflux / drug therapy
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Lansoprazole
  • Omeprazole / adverse effects
  • Omeprazole / analogs & derivatives*
  • Omeprazole / therapeutic use
  • Proton Pump Inhibitors*
  • Stomach Ulcer / drug therapy

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Histamine H2 Antagonists
  • Proton Pump Inhibitors
  • Lansoprazole
  • Omeprazole